Kityo CM - Search Results

1

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min.

Ross LL, Walker AS, Lou Y, Tenorio AR, Gibb DM, Double J, Gilks C, McCoig CC, Munderi P, Musoro G, Kityo CM, Grosskurth H, Hakim J, Mugyenyi PN, Cutrell A, Perger T, Shaefer MS. Ross LL, et al. Among authors: kityo cm. PLoS One. 2019 Nov 14;14(11):e0225199. doi: 10.1371/journal.pone.0225199. eCollection 2019. PLoS One. 2019. PMID: 31725787 Free PMC article.

2

Resistance to antiretroviral therapy among patients in Uganda.

Weidle PJ, Kityo CM, Mugyenyi P, Downing R, Kebba A, Pieniazek D, Respess R, Hertogs K, De Vroey V, Dehertogh P, Bloor S, Larder B, Lackritz E. Weidle PJ, et al. Among authors: kityo cm. J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):495-500. doi: 10.1097/00126334-200104150-00017. J Acquir Immune Defic Syndr. 2001. PMID: 11391172

3

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg DR. Oyugi JH, et al. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1100-2. doi: 10.1097/00126334-200408150-00014. J Acquir Immune Defic Syndr. 2004. PMID: 15247564

4

T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.

Eggena MP, Barugahare B, Okello M, Mutyala S, Jones N, Ma Y, Kityo C, Mugyenyi P, Cao H. Eggena MP, et al. J Infect Dis. 2005 Mar 1;191(5):694-701. doi: 10.1086/427516. Epub 2005 Jan 31. J Infect Dis. 2005. PMID: 15688282

5

Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition.

Barugahare B, Baker C, K'Aluoch O, Donovan R, Elrefaei M, Eggena M, Jones N, Mutalya S, Kityo C, Mugyenyi P, Cao H. Barugahare B, et al. J Virol. 2005 Apr;79(7):4132-9. doi: 10.1128/JVI.79.7.4132-4139.2005. J Virol. 2005. PMID: 15767414 Free PMC article.

6

Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda.

Bateganya M, Colfax G, Shafer LA, Kityo C, Mugyenyi P, Serwadda D, Mayanja H, Bangsberg D. Bateganya M, et al. AIDS Patient Care STDS. 2005 Nov;19(11):760-8. doi: 10.1089/apc.2005.19.760. AIDS Patient Care STDS. 2005. PMID: 16283836

7

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.

Ssali F, Stöhr W, Munderi P, Reid A, Walker AS, Gibb DM, Mugyenyi P, Kityo C, Grosskurth H, Hakim J, Byakwaga H, Katabira E, Darbyshire JH, Gilks CF; DART Trial Team. Ssali F, et al. Antivir Ther. 2006;11(6):741-9. doi: 10.1177/135965350601100612. Antivir Ther. 2006. PMID: 17310818 Clinical Trial.

8

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.

Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, Mugyenyi P, Quinn TC, Bangsberg DR. Oyugi JH, et al. AIDS. 2007 May 11;21(8):965-71. doi: 10.1097/QAD.0b013e32802e6bfa. AIDS. 2007. PMID: 17457090 Clinical Trial.

9

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.

Reid A, Stöhr W, Walker AS, Williams IG, Kityo C, Hughes P, Kambugu A, Gilks CF, Mugyenyi P, Munderi P, Hakim J, Gibb DM; Development of Antiretroviral Therapy Trial. Reid A, et al. Clin Infect Dis. 2008 Apr 15;46(8):1271-81. doi: 10.1086/533468. Clin Infect Dis. 2008. PMID: 18444867

10

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.

Muyingo SK, Walker AS, Reid A, Munderi P, Gibb DM, Ssali F, Levin J, Katabira E, Gilks C, Todd J; DART Trial Team. Muyingo SK, et al. J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):468-75. doi: 10.1097/QAI.0b013e31817dc3fd. J Acquir Immune Defic Syndr. 2008. PMID: 18614918 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters